Chronic myeloid leukemia versus acute myeloid leukemia in patients with retinoblastoma
Oman Journal of Ophthalmology, 2021 Carol L. Shields, Ann-Marie Leahey
openaire +4 more sources
Exploration, EarlyView.Using celastrol as a case study, this review summarizes various target discovery strategies for natural products, including chemical proteomics, protein microarray, degradation‐based protein profiling, proteome‐wide label‐free approaches, network pharmacology, target‐based drug screening, and indirect strategies.
Yanbei Tu +5 more
wiley +1 more source
Monocytoid differentiation of freshly isolated human myeloid leukemia cells and HL-60 cells induced by the glutamine antagonist acivicin [PDF]
, 1989 KE Nichols +3 more
openalex +1 more source
Phenylethanoid Glycosides in Cistanches: Chemistry, Pharmacokinetic, and Antitumor Properties
Food Frontiers, EarlyView.This review systematically summarizes the representative PhGs found in CH species, their pharmacokinetic parameters, and primary metabolites in humans and rats. Additionally, it examines the antitumor activities of PhGs in CH and their associated signaling pathways against various malignancies.
Jie Li +7 more
wiley +1 more source
Preferential response of acute myeloid leukemias with translocation involving chromosome 17 to human recombinant granulocyte colony- stimulating factor [PDF]
, 1988 MJ Pébusque +3 more
openalex +1 more source
Expression of the X-CGD gene during induced differentiation of myeloid leukemia cell line HL-60. [PDF]
, 1988 Kathleen A. Barker +2 more
openalex +3 more sources
High-dose cytosine arabinoside and mitoxantrone: a highly effective regimen in refractory acute myeloid leukemia [PDF]
, 1987 Wolfgang Hiddemann +8 more
openalex +1 more source
Nanotechnology in brain cancer treatment: The role of gold nanoparticles as therapeutic enhancers
Ibrain, EarlyView.This review highlights the potential of gold nanoparticles (AuNPs) in overcoming the blood‐brain barrier (BBB) to improve brain tumor treatment. By enabling targeted drug delivery and enhancing therapies like radiotherapy, phototherapy, and chemotherapy, AuNPs offer a promising approach for safer, more effective treatments of glioblastoma and other ...
Simona Tarantino +4 more
wiley +1 more source
The interleukin 3 gene is located on human chromosome 5 and is deleted in myeloid leukemias with a deletion of 5q. [PDF]
, 1987 Michelle M. Le Beau +6 more
openalex +1 more source